PREVENTION OF KIDNEY DAMAGE IN SYSTEMIC VASCULITIS
Ключевые слова:
Systemic vasculitis, kidney damage, renal involvement, prevention, glomerulonephritisАннотация
Systemic vasculitis is a group of autoimmune diseases characterized by inflammation and destruction of blood vessel walls, leading to impaired blood circulation and damage to various organs. Among the affected organs, the kidneys are particularly vulnerable due to their extensive vascular structure. Renal involvement is one of the most severe complications of systemic vasculitis and may result in chronic kidney disease, end-stage renal failure, and increased mortality. This article aims to analyze the mechanisms of kidney damage in systemic vasculitis and evaluate modern preventive strategies. The study reviews current scientific literature regarding risk factors, clinical manifestations, diagnostic approaches, and nephroprotective interventions. Special attention is given to the importance of early diagnosis, regular monitoring of renal function, timely initiation of immunosuppressive therapy, and effective control of disease activity. The findings indicate that comprehensive preventive measures significantly reduce the risk of renal complications and improve long-term outcomes. Early intervention remains essential for preserving kidney function and enhancing patients’ quality of life
##plugins.themes.default.displayStats.downloads##
Библиографические ссылки
1. Rasulov, A. A., Yuldashev, M. S., & Ergasheva, D. M. (2023). Clinical aspects of renal dysfunction in systemic vasculitis. Journal of Medicine and Practice, 4(2), 45–52.
2. Tursunov, S. T., & Abduvaliyev, O. X. (2020). Fundamentals of clinical nephrology. Tashkent: Fan va Texnologiya Publishing.
3. Yusupov, N. N., & Mamadaliyeva, G. A. (2022). The importance of nephroprotective therapy in autoimmune diseases. Uzbek Therapeutic Bulletin, 3(1), 28–34.
4. Xodjiyeva, Z. B., & Axmedov, F. M. (2021). Modern opportunities of laboratory diagnostics in kidney diseases. Bulletin of Tashkent Medical Academy, 5(3), 61–67.
5. Raximov, J. A., & To‘xtayev, S. M. (2023). Early detection methods of renal complications in systemic vasculitis. Uzbek Medical Journal, 2(4), 39–46.
6. Jennette, J. C., Falk, R. J., Bacon, P. A., et al. (2013). 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis & Rheumatism, 65(1), 1–11.
7. Geetha, D., & Jefferson, J. A. (2020). ANCA-associated vasculitis: Core curriculum 2020. American Journal of Kidney Diseases, 75(1), 124–137.
8. Kitching, A. R., Anders, H. J., Basu, N., et al. (2020). ANCA-associated vasculitis. Nature Reviews Disease Primers, 6(1), 71.
9. Kidney Disease: Improving Global Outcomes (KDIGO). (2021). KDIGO clinical practice guideline for the management of glomerular diseases. Kidney International, 100(Suppl. 4), S1–S276.
10. Kronbichler, A., Lee, K. H., Denicolò, S., et al. (2022). Immunopathogenesis and management of ANCA-associated vasculitis. Clinical Journal of the American Society of Nephrology, 17(5), 784–796.
11. Pendergraft, W. F., & Niles, J. L. (2021). Systemic vasculitis and the kidney. Clinical Journal of the American Society of Nephrology, 16(10), 1577–1589.
12. Yates, M., Watts, R. A., Bajema, I. M., et al. (2022). EULAR recommendations for the management of ANCA-associated vasculitis. Annals of the Rheumatic Diseases, 81(6), 773–789.
13. Merkel, P. A., Niles, J. L., Mertz, L. E., et al. (2021). Current status of outcome measures in vasculitis research. Current Rheumatology Reports, 23(8), 1–12
